Anti-Tumor Necrosis Factor α: Originators Versus Biosimilars, Comparison in Clinical Response Assessment in a Multicenter Cohort of Patients With Inflammatory Arthropathies. Reumatismo 2023, 75 (4). https://doi.org/10.4081/reumatismo.2023.1602.